Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04715399 · ClinicalTrials.gov registry record

UPenn Observational Research Repository on Neurodegenerative Disease

A clinical trial of Primary Progressive Aphasia(PPA) and Corticobasal Syndrome(CBS), sponsored by University of Pennsylvania.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT04715399 is a study of Primary Progressive Aphasia(PPA) and Corticobasal Syndrome(CBS) that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04715399, a study of Primary Progressive Aphasia(PPA) and Corticobasal Syndrome(CBS), is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to create a repository of both cross-sectional and longitudinal data, including cognitive, linguistic, imaging and biofluid biological specimens, for neurodegenerative disease research and treatment.

Interventions

  • OTHER No intervention

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2020-05-29
Est. Completion 2070-05-30

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT04715399

The ClinicalTrials.gov registry entry for NCT04715399 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Primary Progressive Aphasia(PPA) appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT04715399 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04715399 about?

NCT04715399 is a clinical study titled "UPenn Observational Research Repository on Neurodegenerative Disease". The aim of this study is to create a repository of both cross-sectional and longitudinal data, including cognitive, linguistic, imaging and biofluid biological specimens, for neurodegenerative disease research and treatment.

What is the current status of trial NCT04715399?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2020-05-29. Estimated completion is 2070-05-30.

What conditions does trial NCT04715399 study?

This clinical trial studies the following conditions: Primary Progressive Aphasia(PPA), Corticobasal Syndrome(CBS), Frontotemporal Degeneration(FTD), Familial Frontotemporal Lobar Degeneration (fFTLD), Amyotrophic Lateral Sclerosis(ALS).

What interventions are being tested in trial NCT04715399?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT04715399?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04715399 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Primary Progressive Aphasia(PPA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.